{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:50:38Z","timestamp":1783039838116,"version":"3.54.6"},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.2169\/internalmedicine.9613-17","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T22:19:14Z","timestamp":1518128354000},"page":"1899-1903","source":"Crossref","is-referenced-by-count":8,"title":["Primary Central Nervous System Post-transplant Lymphoproliferative Disorder Diagnosed by Peripheral Facial Nerve Palsy"],"prefix":"10.2169","volume":"57","author":[{"given":"Aya","family":"Imafuku","sequence":"first","affiliation":[{"name":"Department of Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiho","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Marui","sequence":"additional","affiliation":[{"name":"Department of Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Ubara","sequence":"additional","affiliation":[{"name":"Department of Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenmei","family":"Takaichi","sequence":"additional","affiliation":[{"name":"Department of Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Tomikawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital, Japan"},{"name":"Department of Pathology, The University of Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Nephrology Center, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Finsterer J. Management of peripheral facial nerve palsy. Eur Arch Otorhinolaryngol 265: 743-752, 2008.","DOI":"10.1007\/s00405-008-0646-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Cavaliere R, Petroni G, Lopes MB, Schiff D. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Cancer 116: 863-870, 2010.","DOI":"10.1002\/cncr.24834"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 4-30, 2002.","DOI":"10.1080\/000164802760370736"},{"key":"4","unstructured":"4. Leonetti JP, Marzo SJ, Anderson DA, Sappington JM. Neoplastic causes of nonacute facial paralysis: a review of 221 cases. Ear Nose Throat J 95: 390-404, 2016."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gupta S, Mends F, Hagiwara M, Fatterpekar G, Roehm PC. Imaging the facial nerve: a contemporary review. Radiol Res Pract 2013: 248039, 2013.","DOI":"10.1155\/2013\/248039"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lake W, Chang JE, Kennedy T, Morgan A, Salamat S, Baskaya MK. A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics. Neurosurgery 72: 960-970, 2013.","DOI":"10.1227\/NEU.0b013e31828cf619"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Caillard S, Lelong C, Pessione F, Moulin B. Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry. Am J Transplant 6: 2735-2742, 2006.","DOI":"10.1111\/j.1600-6143.2006.01540.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Castellano-Sanchez AA, Li S, Qian J, Lagoo A, Weir E, Brat DJ. Primary central nervous system posttransplant lymphoproliferative disorders. Am J Clin Pathol 121: 246-253, 2004.","DOI":"10.1309\/N82CTQ1J0XEVEFQB"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Snanoudj R, Durrbach A, Leblond V, et al. Primary brain lymphomas after kidney transplantation: presentation and outcome. Transplantation 76: 930-937, 2003.","DOI":"10.1097\/01.TP.0000079253.06061.52"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tsai DE, Douglas L, Andreadis C, et al. EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial. Am J Transplant 8: 1016-1024, 2008.","DOI":"10.1111\/j.1600-6143.2008.02183.x"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. van Esser JW, van der Holt B, Meijer E, et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT. Blood 98: 972-978, 2001.","DOI":"10.1182\/blood.V98.4.972"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yaginuma T, Yamamoto H, Mitome J, et al. Successful treatment of monomorphic primary central nervous system post-transplantation lymphoproliferative disorder 5 years after kidney transplantation. Transpl Infect Dis 14: E102-E106, 2012.","DOI":"10.1111\/j.1399-3062.2012.00781.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nozzoli C, Bartolozzi B, Guidi S, et al. Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma 47: 167-169, 2006.","DOI":"10.1080\/10428190500254208"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Boersma MN, van der Zanden A, Laverman GD, Sanders JS, de Vries PA. Epstein-Barr virus-positive post-transplant lymphoproliferative disorder of the central nervous system, after renal transplantation with a discrepancy in viral load between peripheral blood and cerebrospinal fluid. Transpl Int 25: e113-e116, 2012.","DOI":"10.1111\/j.1432-2277.2012.01552.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Terasawa T, Ohashi H, Tsushita K, et al. Failure to detect Epstein-Barr virus (EBV) DNA in plasma by real-time PCR in a case of EBV-associated posttransplantation lymphoproliferative disorder confined to the central nervous system. Int J Hematol 75: 416-420, 2002.","DOI":"10.1007\/BF02982135"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hamadani M, Martin LK, Benson DM, Copelan EA, Devine SM, Hofmeister CC. Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR. Bone Marrow Transplant 39: 249-251, 2007.","DOI":"10.1038\/sj.bmt.1705575"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Paya CV, Fung JJ, Nalesnik MA, et al. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS\/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation 68: 1517-1525, 1999.","DOI":"10.1097\/00007890-199911270-00015"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Piselli P, Serraino D, Segoloni GP, et al. Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009. Eur J Cancer 49: 336-344, 2013.","DOI":"10.1016\/j.ejca.2012.09.013"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Cullis B, D'Souza R, McCullagh P, et al. Sirolimus-induced remission of posttransplantation lymphoproliferative disorder. Am J Kidney Dis 47: e67-e72, 2006.","DOI":"10.1053\/j.ajkd.2006.01.029"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Boratynska M, Smolska D. Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders. Transpl Int 21: 605-608, 2008.","DOI":"10.1111\/j.1432-2277.2008.00655.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ferreira H, Bustorff M, Santos J, et al. Post-transplant lymphoproliferative disorder: a single-center experience. Transplant Proc 47: 981-984, 2015.","DOI":"10.1016\/j.transproceed.2015.03.017"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hiraga S, Arita N, Ohnishi T, et al. Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas. J Neurosurg 91: 221-230, 1999.","DOI":"10.3171\/jns.1999.91.2.0221"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Taj MM, Messahel B, Mycroft J, et al. Efficacy and tolerability of high-dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children. Br J Haematol 140: 191-196, 2008.","DOI":"10.1111\/j.1365-2141.2007.06896.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Khan RB, Shi W, Thaler HT, DeAngelis LM, Abrey LE. Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma? J Neurooncol 58: 175-178, 2002.","DOI":"10.1023\/A:1016077907952"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Buell JF, Gross TG, Hanaway MJ, et al. Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc 37: 954-955, 2005.","DOI":"10.1016\/j.transproceed.2004.12.130"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/13\/57_9613-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T03:45:26Z","timestamp":1530935126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/13\/57_9613-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":25,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9613-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,1]]}}}